Displaying 1 to 2 of 2 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Ajax Therapeutics Inc Blood cancer biotech. |
United States | 13 May 2024 | Series C Initial investment. Round participant. Active |
|
|
Poseida Therapeutics Inc |
United States | 22 Apr 2019 | Series C Round participant. Active |